VCEL
Vericel Corp
NASDAQ · Healthcare · Biotechnology · US
$40.02
−0.02%Forward multiples
Based on analyst estimates
- P/E forward
- 57.02x
- P/E 2026E
- 74.48x
- P/E 2027E
- 46.00x
- P/E 2028E
- 29.80x
- P/S forward
- 5.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- 83.38x
- PEG TTM
- 1.79x
- Price / book
- 5.54x
- Price / sales
- 6.69x
- Price / cash flow
- 29.41x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 6.46x
- EV / EBITDA
- 51.47x
- EV / EBIT
- 108.55x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026